BioNTech SE Tech Stack
mRNA immunotherapy company scaling manufacturing and clinical operations globally
BioNTech develops mRNA-based therapies for cancer and infectious diseases, with a 1,000+ person operation anchored in Mainz and expanding across the US, UK, China, Rwanda, and Australia. The hiring velocity (173 roles posted in 30 days, accelerating) is heavily weighted toward manufacturing (78), ops (47), and research (37)—reflecting a company moving from development into commercial-scale production. Active projects span SAP implementation, technology transfer, and GMP compliance frameworks, while pain points cluster around regulatory readiness and vendor oversight, signaling the operational friction of scaling a biotech from lab to clinic to market.
Tech Stack 124 technologies
What BioNTech SE Is Building
◆Challenges
- Ensuring gmp compliance
- Compliance with chinese safety regulations
- Inspection readiness
- Risk mitigation
- Vendor oversight
- Audit readiness
- Budget and cost control
- Technical transfer challenges
- Optimizing clinical trial performance
- Maintaining compliance with evolving gxp requirements
▲Active Projects
- Technology transfer
- Capa plan development
- Implementing sap
- Risk-based quality strategy implementation
- Category strategy development
- Regulatory strategy development for oncology therapies
- Primary market research for oncology launches
- Clinical trial support
- New system selection and implementation
- Sop development and training
Hiring Activity
Department
Seniority
Notable leadership hires: Clinical Development Director, Analytical Transfer Lead, Commercial Digital Director, Clinical Operations Director, IT Director
